The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.

Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...

The deal gives Cullinan T cell engagers aimed at BCMA and CD19, which drugmakers are exploring as possible targets for ...

Cullinan Therapeutics is paying $20 million upfront for a BCMAxCD3 bispecific T cell engager that the biotech plans to pair ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing ...

More than 200 inmates escaped from a jail in the southern Pakistani city of Karachi late on Monday when they overpowered ...

Immune cells play fundamental roles in the development, progression, and resolution of both chronic inflammatory diseases and various cancer types. In ...

Red light therapy can help improve skin texture, wound healing, and pain. The key to success is using it consistently and ...

A new study will evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in relapsed or refractory autoimmune diseases including antineutrophil cytoplasmic antibody ...

A Form 8-K outlining the full terms of the new credit facility will be filed with the Securities and Exchange Commission.